Table 4.
Group | Hyp (μg·g−1) |
---|---|
NC | 99.32 ± 7.05 |
MC (CCl4) | 413.17 ± 33.76 b |
CCl4 + LE (100 mg/kg b.w.) | 342.32 ± 20.17 d |
CCl4 + LE (150 mg/kg b.w.) | 306.15 ± 26.08 d |
CCl4 + LE (300 mg/kg b.w.) | 174.63 ± 13.64 d |
CCl4 + bifendate | 149.27 ± 11.07 d |
P < 0.01, compared with NC group;
P < 0.01, compared with CCl4-treated group; NC: normal control.